WebRoche/Spark: UK CMA Inquiry Creates Potential Timing, Venue Challenges - The Capitol Forum Manage Cookie Consent To provide the best experiences, we use technologies like …

Court confirms long reach of UK merger control jurisdiction

WebDec 17, 2024 · The CMA has cleared the anticipated purchase of gene therapy company Spark Therapeutics by pharmaceutical company Roche Holdings. The Competition and … WebJun 14, 2024 · Swiss drugmaker, Roche was hoping to tie up the acquisition of gene therapy firm, Spark Therapeutics for $4.8 billion by the second quarter of this year, but a request for additional information and documentary material from the U.S. Federal Trade Commission (FTC) may have put paid to those hopes. Both companies stated that, in spite of the ... topps embossed

Regulatory Demands Further Delay Roche’s Acquisition Of Spark ...

WebOct 28, 2024 · Roche said it extended its tender offer for shares of Spark Therapeutics, Inc. until Nov. 25 to give the U.S. Federal Trade Commission (FTC) and the UK Competition and Markets Authority (CMA) more ... WebSep 3, 2024 · The parties remain committed to the transaction and are working cooperatively and expeditiously with the FTC and the CMA," a statement said. Roche, Spark again extend $4.3 billion takeover offer ... WebApplication in Roche/Spark and rejection of the Parties’ defences The Parties disputed the CMA’s jurisdiction for three reasons: 1. Spark was not active in the supply of Hem A products in the UK; 2. the CMA’s description of goods under the Share of Supply Test was not reasonable; and 3. topps education